At the news
? MIXEDIMPACT 6/10 PRESS-RELEASE filed Jun 15, 2026 at 07:27 ET
Nano Dimension (NNDM) announces a non-binding term sheet to acquire Infinite Epigenetics for $890M, pivoting from 3D printing to healthcare AI. The combined company would have over $400M cash and trade as IEAI, with NNDM shareholders retaining a minority stake at a 20% premium to net cash. The deal is transformative but non-binding and subject to due diligence, negotiations, and approvals.
- Transaction valued at $890 million for Infinite Epigenetics
- Combined company expected to have over $400 million cash at closing
- Existing NNDM shareholders retain meaningful minority ownership at a 20% premium to estimated net cash
- NNDM shareholders to receive a CVR tied to proceeds from legacy asset sales
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access